KR100687037B1 - Composition for nano carrier comprising extract of licorice, tocopherol and balsam, oral care product using it - Google Patents

Composition for nano carrier comprising extract of licorice, tocopherol and balsam, oral care product using it Download PDF

Info

Publication number
KR100687037B1
KR100687037B1 KR1020040024228A KR20040024228A KR100687037B1 KR 100687037 B1 KR100687037 B1 KR 100687037B1 KR 1020040024228 A KR1020040024228 A KR 1020040024228A KR 20040024228 A KR20040024228 A KR 20040024228A KR 100687037 B1 KR100687037 B1 KR 100687037B1
Authority
KR
South Korea
Prior art keywords
tocopherol
balsam
nanocarrier
weight
extract
Prior art date
Application number
KR1020040024228A
Other languages
Korean (ko)
Other versions
KR20050098701A (en
Inventor
지홍근
문군모
최정식
Original Assignee
이광승
동성제약주식회사
(주) 그린생활건강
유효경
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이광승, 동성제약주식회사, (주) 그린생활건강, 유효경 filed Critical 이광승
Priority to KR1020040024228A priority Critical patent/KR100687037B1/en
Publication of KR20050098701A publication Critical patent/KR20050098701A/en
Application granted granted Critical
Publication of KR100687037B1 publication Critical patent/KR100687037B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A47FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47CCHAIRS; SOFAS; BEDS
    • A47C31/00Details or accessories for chairs, beds, or the like, not provided for in other groups of this subclass, e.g. upholstery fasteners, mattress protectors, stretching devices for mattress nets
    • A47C31/10Loose or removable furniture covers
    • A47C31/105Loose or removable furniture covers for mattresses
    • AHUMAN NECESSITIES
    • A47FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47CCHAIRS; SOFAS; BEDS
    • A47C21/00Attachments for beds, e.g. sheet holders, bed-cover holders; Ventilating, cooling or heating means in connection with bedsteads or mattresses
    • A47C21/04Devices for ventilating, cooling or heating
    • A47C21/048Devices for ventilating, cooling or heating for heating
    • AHUMAN NECESSITIES
    • A47FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47CCHAIRS; SOFAS; BEDS
    • A47C31/00Details or accessories for chairs, beds, or the like, not provided for in other groups of this subclass, e.g. upholstery fasteners, mattress protectors, stretching devices for mattress nets
    • A47C31/004Means for protecting against undesired influence, e.g. magnetic radiation or static electricity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/007Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 감초추출물, 토코페롤 및 발삼을 함유한 나노 캐리어 조성물 및 이를 이용한 오랄 케어 제품에 관한 것으로, 더욱 상세하게는 레시틴 1-5.00중량%, 에탄올 1-20.00중량%, 카프릭/카프릴릭 트리글리세라이드 1-5.00중량%, 발삼추출물 1-20.00중량%, 토코페롤 아세테이트 1-20.00중량%, 유용성 감초 추출물 0.001-1.00중량%, 세틸포스페이트 0.01-1.00중량%, 비타민 C 0.001-1.00중량%, BHT 0.1-0.5중량%, 정제수(balance)를 포함하는 나노 캐리어 조성물 및 이를 구강위생 제품의 용도에 적용한 것이다.The present invention relates to a nanocarrier composition containing licorice extract, tocopherol and balsam and oral care products using the same, more specifically 1-5.00 wt% lecithin, 1-20.00 wt% ethanol, capric / caprylic trigly 1-5.00% ceride, 1-20.00% balsam extract, 1-20.00% tocopherol acetate, 0.001-1.00% oil soluble licorice extract, 0.01-1.00% cetylphosphate, 0.001-1.00% vitamin C, BHT 0.1 Nanocarrier composition comprising -0.5% by weight, purified water, and it is applied to the use of oral hygiene products.

본 발명에 의한 나노 캐리어를 이용할 경우, 구강에 유효한 약효성분인 감초추출물, 토코페롤, 발삼 등의 구강내 침투력을 향상시킬 수 있게 되어, 상기 나노 캐리어를 구강위생 제품에 적용하는 경우 뛰어난 치은염 예방 효과 및 치주질환 예방 효과를 얻을 수 있게 된다.When using the nanocarrier according to the present invention, it is possible to improve the oral penetration ability of licorice extract, tocopherol, balsam, etc., which are effective medicinal ingredients in the oral cavity. It is possible to obtain a periodontal disease prevention effect.

나노 캐리어, 감초, 토코페롤, 발삼, 구강위생 Nano Carrier, Licorice, Tocopherol, Balsam, Oral Hygiene

Description

감초 추출물, 토코페롤 및 발삼을 함유한 나노 캐리어 조성물, 이를 이용한 구강 위생 제품{COMPOSITION FOR NANO CARRIER COMPRISING EXTRACT OF LICORICE, TOCOPHEROL AND BALSAM, ORAL CARE PRODUCT USING IT} Nano Carrier Composition Containing Licorice Extract, Tocopherol and Balsam, Oral Hygiene Products Using the Same {Opposite for NANO CARRIER COMPRISING EXTRACT OF LICORICE, TOCOPHEROL AND BALSAM, ORAL CARE PRODUCT USING IT}             

도 1은 본 발명에 의하여 제조된 나노 캐리어의 입자 크기 분포를 나타내는 그래프이다.1 is a graph showing the particle size distribution of the nanocarriers produced by the present invention.

도 2는 본 발명에 의하여 제조된 나노 캐리어 입자의 동결 전자 현미경 사진이다.2 is a frozen electron micrograph of the nanocarrier particles produced by the present invention.

본 발명은 구강용 약효 성분을 함유한 조성물 및 이를 이용한 구강위생 제품에 관한 것으로, 보다 상세하게는 상기 약효 성분의 구강 점막 침투력이 증가된 구강용 조성물 및 이를 이용한 구강위생 제품에 관한 것이다.The present invention relates to a composition containing an oral medicinal ingredient and an oral hygiene product using the same, and more particularly, to an oral composition and an oral hygiene product using the same oral mucosa penetration of the active ingredient.

일반적으로 구강 위생 증진을 위한 조성물이 주로 이용되는 경우로는, 의약품을 제외하고는, 치약, 구강 세정액, 츄잉껌 등을 들 수 있다. 이 들 조성물은 제 품의 특징에 따라 여러가지로 다르게 나타나기도 하나 상기 구강 위생 증진용 조성물의 개발은 기본적으로 충치예방, 치주질환예방, 구취제거 등에 초점이 맞춰져 있다. In general, when the composition for promoting oral hygiene is mainly used, except for pharmaceuticals, toothpaste, oral cleaning liquid, chewing gum and the like can be mentioned. These compositions may appear differently depending on the characteristics of the product, but the development of the composition for promoting oral hygiene is basically focused on preventing caries, preventing periodontal disease, and removing bad breath.

따라서, 구강 위생 제품도 충치예방, 치주질환 등에 효과가 있는 성분들을 함유한 각종 조성물을 이용하여 제조되고 있는데, 자일리톨, 불소, 녹차추출물, 감초추출물 등 이외에도, 각종 생약성분을 포함한 조성물 등이 많이 이용되고 있는 추세이다.Therefore, oral hygiene products are also manufactured using various compositions containing ingredients that are effective in preventing tooth decay, periodontal disease, etc. In addition to xylitol, fluorine, green tea extract, licorice extract, and the like, various compositions containing various herbal ingredients are used. It is becoming a trend.

그러나, 종래에 구강 위생에 유효한 성분을 함유한 구강위생제품의 경우 비록 치주질환 등에 유효한 성분을 함유하고 있다고는 할 지라도, 상기 조성물을 그대로 이용하는 경우가 많아 생체에는 거의 흡수되지 않아서 실제로 치주질환 등의 예방 효과를 크게 기대할 수 없었다. 즉, 예컨대, 치약이 감초추출물 등을 함유하고 있다고 하더라도, 양치질을 하고 있는 짧은 시간 동안에 체내로 흡수되지 않는 이상, 상기 유효성분에 의한 효과는 거의 볼 수 없다는 문제점이 있었다. However, conventionally, oral hygiene products containing ingredients effective for oral hygiene, even though they contain ingredients effective for periodontal disease, etc., the composition is often used as it is, so it is hardly absorbed by the living body, such as periodontal disease actually The preventive effect could not be greatly expected. That is, even if the toothpaste contains licorice extract, for example, there is a problem that the effect by the active ingredient is hardly seen unless it is absorbed into the body for a short time while brushing teeth.

또한, 1999년 7월 15일에 공개된 대한민국 공개공보 특1999-0053087에서는, 오배자, 감초, 황금을 일정 비율로 복합 추출한 추출물을 200 내지 2,000 마이크로미터 크기로 캡슐화한 구강위생 증진용 조성물을 개시 하고 있으나, 이는 치약의 경시 안정성 및 사용성을 개선할 수 있는 방법에 지나지 않으며, 생약성분제제의 생체흡수율을 높일 수 있는 방법은 아니다. 결국, 각종 약효성분을 캡슐화하여 이용하는 경우에도 그대로 사용하는 경우와 유사하게 여전히 상기 약효성분들의 생체 흡수율이 낮다고 하는 문제점이 있었다. In addition, Korean Laid-Open Patent Publication No. 1999-0053087 published on July 15, 1999, discloses a composition for oral hygiene enhancement encapsulated in 200 to 2,000 micrometers sized extract of the complex extracted five times gall, licorice, gold in a certain ratio However, this is only a method for improving the stability and usability of the toothpaste over time, and is not a method for increasing the bioabsorption rate of the herbal preparations. As a result, in the case of encapsulating and using various active ingredients, there is still a problem that the bioabsorption rate of the active ingredients is low.

따라서, 구강 위생 증진용 조성물 내에서 치주질환 등을 예방할 수 있는 물질 자체의 안정성을 높일 수 있는 방법 및 상기 물질의 생체 침투력을 높여 그 효과를 증대시킬 수 있는 방법이 지속적으로 요구되어 오고 있다.Therefore, there has been a continuous need for a method of increasing the stability of the substance itself that can prevent periodontal disease and the like in the composition for promoting oral hygiene and a method of increasing the effect of increasing the biological penetration of the substance.

상기와 같은 문제점을 해결하기 위하여 본 발명은 변색이 심하고 유용성 오일에 잘 녹지 않으며, 체내 흡수력이 낮은 유용성 감초 추출물, 피부나 잇몸, 체내 흡수력이 늦은 토코페롤 아세테이트 및 충치균에 효과적인 발삼 추출물 등에 대한 구강 점막 침투력을 증진시키는 것과 동시에 구강위생 제품내에서의 안정성을 높이는데 그 목적이 있다.
In order to solve the above problems, the present invention has a severe discoloration and does not dissolve well in oil-soluble oils, oil-soluble licorice extract with low absorption of the body, skin or gums, tocopherol acetate and late balm extracts effective against caries bacteria, oral mucosal penetration ability The purpose is to increase the stability in the oral hygiene products at the same time.

상기와 같은 목적을 달성하기 위하여, 본 발명은 레시틴 1-5.00중량%, 에탄올 1-20.00중량%, 카프릭/카프릴릭 트리글리세라이드 1-5.00중량%, 발삼추출물 1-20.00중량%, 토코페롤 아세테이트 1-20.00중량%, 유용성 감초 추출물 0.001-1.00중량%, 세틸포스페이트 0.01-1.00중량%, 비타민 C 0.001-1.00중량%, BHT 0.1-0.5중량%, 정제수(balance)를 포함하는 나노 캐리어 조성물 및 이를 이용한 구강위생 제품을 제공한다.In order to achieve the above object, the present invention is 1-5.00% by weight of lecithin, 1-20.00% by weight of ethanol, 1-5.00% by weight of capric / caprylic triglycerides, 1-20.00% by weight of balsam extract, tocopherol acetate Nanocarrier composition comprising 1-20.00 wt%, oil-soluble licorice extract 0.001-1.00 wt%, cetylphosphate 0.01-1.00 wt%, vitamin C 0.001-1.00 wt%, BHT 0.1-0.5 wt%, purified water Provide oral hygiene products used.

이로써, 감초 추출물, 발삼, 토코페롤 성분 등의 생체침투능력이 향상되어 상기 유효성분의 효과를 극대화할 수 있게 되는 것이다.As a result, the biopermeability of licorice extract, balsam, tocopherol components and the like is improved to maximize the effect of the active ingredient.

이하에서, 본 발명의 구성을 더욱 상세히 설명하도록 한다.Hereinafter, the configuration of the present invention to be described in more detail.

본 발명의 나노 캐리어 조성물은 특히 발삼추출물 1-20.00중량%, 토코페롤 아세테이트 1-20.00중량%, 유용성 감초 추출물 0.001-1.00중량%를 포함한다.In particular, the nanocarrier composition of the present invention contains 1-20.00% by weight of balsam extract, 1-20.00% by weight of tocopherol acetate, and 0.001-1.00% by weight of oil-soluble licorice extract.

이 중 발삼은 침엽수에서 분비되는 끈적끈적한 액체이며, 천연수지(natural resins)의 하나이다. 발삼에는 방부, 항염증, 항균 효과가 있으며, 특히 충치균에 효과가 있다. 본 발명에서의 나노 캐리어 조성물은 상기와 같은 효능이 있는 발삼추출물을 1-20.00중량% 함유하고 있다.Balsam is a sticky liquid secreted from conifers and is one of natural resins. Balsam has antiseptic, anti-inflammatory, and antibacterial effects, especially against caries. Nanocarrier composition in the present invention contains 1-20.00% by weight of balsam extract having the above-described efficacy.

본 발명의 나노 캐리어 조성물은 또한 유용성 감초 추출물을 포함하는데, 감초는 콩과에 속하는 다년생 식물인 감초의 뿌리로서, 홍갈색 또는 암갈색이고 맛은 달고 독이 없다. 감초의 효능으로는 해독작용이 있고, 비장의 기능과 기력을 돕고, 종기를 제거하며, 여러가지 약을 고르게 조화시켜 준다. 본 발명의 나노 캐리어 조성물에서는 상기와 같은 효능이 있는 유용성 감초 추출물을 0.001-1.00중량% 포함하고 있다.The nanocarrier composition of the present invention also includes an oil-soluble licorice extract, which is the root of licorice, a perennial plant belonging to the legume, which is reddish brown or dark brown, tastes sweet and nonpoisonous. Licorice has the detoxification effect, helps the function and energy of the spleen, removes boils, and evenly harmonizes various medicines. The nanocarrier composition of the present invention contains 0.001-1.00% by weight of an oil-soluble licorice extract having the above-described efficacy.

또한, 본 발명의 나노 캐리어 조성물은 토코페롤 아세테이트를 1-20.00중량% 함유하고 있는데, 토코페롤은 비타민 E로서, 콩기름, 채종유, 면실유, 야자유 등 식물성 기름에 많이 함유되어 있으며 물에는 용해되지 않고 독성이 없다. 토코페롤은 생체 내에서는 활성 산소를 소거시켜 유리기와 과산화지질의 생성을 억제하는 항산화 작용을 한다. 토코페롤 자체는 불안정하여 그 유도체를 많이 사용하게 되는데 특히 비타민 아세테이트, 비타민 팔미테이트 등이 주로 사용되며, 본 발명에서 의 나노 캐리어 조성물에서는 토코페롤 아세테이트를 사용한다. 비타민 E는 또한 심한 치주 질환에 효과가 있다. 특히 동물실험에 의해서 밝혀진 바에 의하면 토코페롤이 은의 독성을 감소 시키므로, 치아에 은도금이 있는 경우 토코페롤의 항산화 효과가 꼭 필요하다.In addition, the nanocarrier composition of the present invention contains 1-20.00% by weight of tocopherol acetate. Tocopherol is a vitamin E, which is contained in vegetable oils such as soybean oil, rapeseed oil, cottonseed oil, and palm oil. . Tocopherol acts as an antioxidant that inhibits the production of free radicals and lipid peroxide by scavenging free radicals in vivo. Tocopherol itself is unstable to use a lot of its derivatives, in particular vitamin acetate, vitamin palmitate, etc. are mainly used, the tocopherol acetate is used in the nanocarrier composition of the present invention. Vitamin E is also effective in severe periodontal disease. In particular, animal studies have shown that tocopherol reduces silver toxicity, so if the tooth is silver plated, the antioxidant effect of tocopherol is essential.

본 발명에서는 상기와 같은 구강 유효 물질 즉, 구내염, 상기도염, 기관지염 등의 각종 염증에 효과가 있는 감초 추출물과, 항염증, 항균 효과가 있는 발삼, 그리고 항산화작용, 면역기능 증강, 상처 치유 촉진작용 및 치주질환에 효과가 있는 토코페롤 성분 등과 같이 충치, 치은염, 치주질환 등에 효과가 있으나, 생체 흡수율이 낮은 유용성 물질을 나노 캐리어화하여 이용한다.In the present invention, the oral effective substance as described above, that is, licorice extract which is effective in various inflammations, such as stomatitis, upper respiratory tract, bronchitis, anti-inflammatory, antibacterial balsam, and antioxidant action, immune function enhancement, wound healing promoting action And tocopherol component that is effective in periodontal disease, such as caries, gingivitis, periodontal disease is effective, but low bio-absorption useful material is used by nano-carrier.

본 발명에서의 나노 캐리어는 주로 리포좀과 나노 에멀젼의 2가지 형태로 이루어져 있다. 그 중에서 포스파티딜 콜린(phosphatidyl choline : PC), 포스파티딜 에탄올아민(phosphatidyl ethanolamine: PE), 포스파티딜 세린(phosphatidyl serine :PS), 스핑고마이엘린(sphingomyelins), 카디오리피드(cardiolipids), 플라즈마로겐(plasmalogens), 포스파티딘산(phosphatidic acid), 세레브로사이드( cerebroside)와 같은 인지질로 구성되어 있는 이중층 폐쇄막을 형성하여 물과 평형 상태에 있는 분자단을 리포좀이라 한다. 지질 구성 성분들은 양친매성 성질을 자체내에 갖고 있어 극성(친수성)인 하이드로필릭 부위와 비극성(친유성)인 리포필릭 부위를 가진다. 그러므로 리포좀은 물에 분산 시켰을 때 구상이 아닌 2 분자막 (bilayer)을 형성하여 수상 성분을 포집한다. 이에 비하여 나노 에멀젼은 유상 성분을 포집한다. 따라서, 이를 이용하여 나노 캐리어를 제조함으로써 나노에멀젼으 로 내부에 난용성 물질(예를 들면 토코페롤, 레티놀 등)을, 리포좀을 이용하여 낮은 생체 이용율을 가진 물질(예를 들면 감초추출물, 발삼 등)을 포집하도록 하여 이들의 생체 이용율을 증진 시킬 수 있게 되는 것이다. 또한 이것을 제품을 통해 활용함으로써, 생리활성물질을 선택적으로 입속의 점막, 잇몸 기타 피부에 빠르게 흡수되도록 하여, 결국 충치 예방, 치은염 예방, 치주질환예방 등의 효과를 증대시킬수 있게 되는 것이다.Nanocarriers in the present invention mainly consists of two forms, liposomes and nanoemulsions. Among them, phosphatidyl choline (PC), phosphatidyl ethanolamine (PE), phosphatidyl serine (PS), sphingomyelins, cardiolipids, plasmalogens (plasmalogens) Liposomes in equilibrium with water are formed by forming a bilayer closed membrane composed of phospholipids such as phosphatidic acid and cerebroside. Lipid components have amphiphilic properties in themselves and thus have polar (hydrophilic) hydrophilic sites and nonpolar (lipophilic) lipophilic sites. Therefore, liposomes, when dispersed in water, form a bilayer, rather than a spherical form, to capture the aqueous phase. In contrast, nanoemulsions collect oily components. Therefore, the nano-carrier is used to prepare a poorly soluble substance (eg, tocopherol, retinol, etc.) inside the nanoemulsion, and a material having low bioavailability (eg, licorice extract, balsam, etc.) using liposomes. It will be able to enhance their bioavailability by collecting. In addition, by utilizing this through the product, the biologically active material is selectively absorbed into the mucous membranes of the mouth, gums and other skin, thereby increasing the effects of caries prevention, gingivitis prevention, and periodontal disease prevention.

그러나, 상기 나노 캐리어는 입자 크기가 너무 미세하여 일반적인 광학 현미경으로는 그 측정이 불가능하다. 따라서, 도 2와 같이 동결 전자현미경(Photo Graphing Freeze-Fracture Scanning Electron Microscopy)을 이용하여 사진을 찍음으로써 확인할 수 있게 된다. 도 2에서 동그랗게 튀어나온 부분은 모노레이어로 된 나노 에멀젼 부분이고, 동그랗게 들어간 부분은 바이레이어인 리포좀이다. 즉, 나노 캐리어는 나노 에멀젼과 리포좀이 합쳐져서 된 것임을 알 수 있다. However, the nanocarriers are so small in particle size that they cannot be measured by a general optical microscope. Therefore, as shown in Figure 2 it can be confirmed by taking a picture by using a Photo Graphing Freeze-Fracture Scanning Electron Microscopy. In FIG. 2, the protruding part is a nanoemulsion part in monolayer, and the part is a liposome that is a bilayer. That is, it can be seen that the nanocarrier is a combination of nanoemulsion and liposome.

본 발명인 나노 캐리어의 조성물에 의하여 제조된 나노 캐리어는, 도 1에서 볼 수 있는 바와 같이, 나노 캐리어의 입자분포를 제타 포텐셜 분석기 (Malvern, Zetasizer 1000HS)를 이용해서 측정한 결과 입자의 크기가 20-300nm임을 알 수 있었다. 따라서, 세포간 지질 사이가 200-300nm이고, 본 발명에 의한 나노 캐리어가 20-300nm이므로, 본 발명에 의한 나노 캐리어를 이용할 경우 상기 나노 캐리어에 포집된 유효 성분이 잇몸 등에 매우 빠르게 침투될 수 있는 것이다. As can be seen in Figure 1, the nanocarrier prepared by the composition of the nano-carrier of the present invention, the particle size of the nano-carrier was measured using a Zeta Potential Analyzer (Malvern, Zetasizer 1000HS) results in a particle size of 20- It was found that it is 300nm. Therefore, since the intercellular lipids are 200-300nm and the nanocarriers according to the present invention are 20-300nm, when the nanocarriers according to the present invention are used, the active ingredient collected in the nanocarriers can be rapidly penetrated to the gums and the like. will be.

본 발명은 또한 상기 나노 캐리어 조성물에 의하여 제조된 나노 캐리어를 포함하는 구강 위생 제품을 제공한다.The present invention also provides an oral care product comprising a nano carrier prepared by the nano carrier composition.

구강 위생 제품은 나노 캐리어 이외에도 연마제, 보습제, 결합제, 기포제, 감미료, 방부제, 향료, pH조정제, 증백제 등을 포함할 수 있다.In addition to nanocarriers, oral care products may include abrasives, humectants, binders, foaming agents, sweeteners, preservatives, fragrances, pH adjusters, brighteners, and the like.

이하, 본 발명의 바람직한 실시예를 통하여, 본 발명을 더욱 상세히 설명하기로 한다. 다만, 이에 따라 본 발명의 권리범위가 정해지는 것은 아니며, 다만 하나의 예시로 제시된 것이다.Hereinafter, the present invention will be described in more detail with reference to preferred embodiments of the present invention. However, the scope of the present invention is not determined accordingly, but is presented by way of example only.

[실시예]EXAMPLE

실시예 1 : 발삼추출물과 토코페롤 아세테이트, 유용성 감초를 이용한 나노캐리어의 제조Example 1 Preparation of Nanocarriers Using Balsam Extract, Tocopherol Acetate and Oil-Soluble Licorice

레시틴 1-5.00중량%, 에탄올 1-20.00중량%, 카프릭/카프릴릭 트리글리세라이드 1-5.00중량%, 발삼추출물 1-20.00중량%, 토코페롤 아세테이트 1-20.00중량%, 유용성 감초 추출물 0.001-1.00중량%, 세틸포스페이트0.01-1.00중량%, 비타민 C 0.001-1.00중량%, BHT 0.1-0.5중량%에 정제수를 넣어서 합계 100중량%를 만든다. 상기 나노 캐리어 조성물을 혼합 교반하고 고압 미세 균질기를 통과 시킨 후 냉각, 탈포함으로써 나노 캐리어를 제조하였다.1-5.00% lecithin, 1-20.00% ethanol, 1-5.00% capric / caprylic triglyceride, 1-20.00% balsam extract, 1-20.00% tocopherol acetate, oil-soluble licorice extract 0.001-1.00 100% by weight of purified water is added to the weight%, cetyl phosphate 0.01 to 1.00% by weight, vitamin C 0.001-1.00% by weight, BHT 0.1-0.5% by weight. The nanocarrier was prepared by mixing and stirring the nanocarrier composition, and passing the high pressure fine homogenizer, followed by cooling and defoaming.

도 1에서 볼 수 있는 바와 같이, 상기에서 제조한 나노 캐리어의 입자분포를 제타 포텐셜 분석기(Malvern, Zetasizer 1000HS)를 이용해서 측정한 결과, 입자의 크기가 20-300nm이었으며, 특히 50-100nm에서 가장 많은 분포를 보임을 알 수 있었 다.As can be seen in Figure 1, the particle size distribution of the nano-carriers prepared above was measured using a Zeta Potential Analyzer (Malvern, Zetasizer 1000HS), the particle size was 20-300nm, especially at 50-100nm Many distributions were found.

실시예 2 : 나노캐리어 함유 치약의 제조Example 2 Preparation of Nanocarrier-Containing Toothpaste

준비공정으로서, a)의 성분들을 70 내지 75℃의 온도로 제조부에 투입한후 20분간 교반하여 분체를 완전히 용해한뒤 상온으로 냉각하였다. 이어서 보습제, 감미료 및 유용성분의 용해공정으로서, 상기 실시예 1에서 얻어진 나노 캐리어를 포함하는 b)성분들을 25 내지 35℃로 제조부에 투입한 후 15분간 교반 혼합하여 용해하였다. 다음은 분체 및 점성제 혼합공정으로서, c)성분들을 25 내지 35℃에서 혼합해서 단계적으로 투입하였다. 이후 기포제 혼합 및 1차 탈포공정으로서, d)성분을 첨가하여 25-35℃에서 40분간의 공정 동안에 1차 탈포를 완료한다. 마지막으로 향 혼합공정으로서, e)성분을 첨가하고 25 내지 35℃에서 2차 탈포하여 나노캐리어 함유 치약을 제조하였다.As a preparation step, the components of a) were introduced into the production unit at a temperature of 70 to 75 ° C. and stirred for 20 minutes to completely dissolve the powder and then cooled to room temperature. Subsequently, as a dissolving step of the moisturizer, sweetener and useful ingredient, b) components including the nanocarrier obtained in Example 1 were added to the preparation unit at 25 to 35 ° C., followed by stirring for 15 minutes to dissolve. The following is a powder and viscous mixing process, in which c) components were mixed at 25 to 35 ° C. and added stepwise. Thereafter, as the foaming agent mixing and primary defoaming step, d) component is added to complete the primary defoaming during the 40 minute process at 25-35 ° C. Finally, as a fragrance mixing process, the nanocarrier-containing toothpaste was prepared by adding e) component and performing secondary degassing at 25 to 35 ° C.

나노캐리어 함유 치약(1)Nanocarrier-containing toothpaste (1)

a)정제수 합계 100중량%를 만든다a) Make total weight of purified water 100%

b)글리세린 6.00중량%b) 6.00% by weight glycerin

솔비톨 35.00중량%  Sorbitol 35.00 wt%

삭카린나트륨 0.10중량%  Zaccarin Sodium 0.10% by weight

나노캐리어 1.00-20.00중량%  Nano Carrier 1.00-20.00% by weight

c)실리카 7.00중량%c) 7.00 wt% silica

침강탄산칼슘 39.00중량%  Precipitated Calcium Carbonate 39.00% by weight

d)라우릴황산나트륨 2.00중량%d) 2.00% by weight of sodium lauryl sulfate

e)멘톨 0.40중량%e) menthol 0.40% by weight

박하유 0.10중량%  Peppermint oil 0.10% by weight

나노캐리어 함유 치약(2) Nanocarrier-containing toothpaste (2)

a)일불소인산나트륨 0.75중량%a) 0.75% by weight sodium monofluorophosphate

정제수 합계 100중량%를 만든다  Makes 100% by weight of purified water in total

b)아미노카프론산 0.10중량%b) 0.10% by weight of aminocaproic acid

염화나트륨 4.50중량%  4.50 wt% sodium chloride

글리세린 4.00중량%  Glycerin 4.00 wt%

솔비톨 35.00중량%  Sorbitol 35.00 wt%

나노캐리어 1.00-20.00중량%  Nano Carrier 1.00-20.00% by weight

c)콜로이드성이산화규소 15.00중량%c) 15.00 wt% colloidal silicon oxide

d)폴리에틸렌글리콜1500 4.00중량%d) polyethylene glycol 1500 4.00% by weight

나노캐리어 함유 치약(3)Nanocarrier-containing toothpaste (3)

a)일불소인산나트륨 0.75중량%a) 0.75% by weight sodium monofluorophosphate

정제수 합계 100중량%를 만든다  Makes 100% by weight of purified water in total

b)솔비톨 30.00중량%b) sorbitol 30.00 wt%

글리세린 5.00중량%  Glycerin 5.00 wt%

삭카린나트륨 0.20중량%  Zaccarin Sodium 0.20% by weight

염화나트륨 0.20중량%  Sodium chloride 0.20 wt%

나노캐리어 1.00-20.00중량%  Nano Carrier 1.00-20.00% by weight

c)이산화규소 15.00중량%c) 15.00 wt% of silicon dioxide

실리카 6.00중량%  6.00% by weight of silica

카르복시메틸셀룰로오스 1.00중량%  1.00% by weight of carboxymethyl cellulose

d)라우릴황산나트륨 2.00중량%d) 2.00% by weight of sodium lauryl sulfate

나노캐리어 함유 치약(4)Nanocarrier-containing toothpaste (4)

a)정제수 합계 100중량%를 만든다a) Make total weight of purified water 100%

b)솔비톨 20.00중량%b) sorbitol 20.00 wt%

글리세린 5.00중량%  Glycerin 5.00 wt%

나노캐리어 1.00-20.00중량%  Nano Carrier 1.00-20.00% by weight

c)탄산칼슘 30.00중량%c) calcium carbonate 30.00% by weight

인산일수소칼슘 12.00중량%  Calcium Dihydrogen Phosphate 12.00% by weight

실리카 3.00중량%  3.00 wt% silica

카르복실메틸셀룰로오스 0.70중량%  Carboxymethyl cellulose 0.70 wt%

d)라우릴황산나트륨 1.50중량%d) 1.50% by weight of sodium lauryl sulfate

실시예 3 :Example 3: 경피흡수율 측정 실험 Percutaneous absorption rate measurement experiment

실시예 2에서 제조된 나노 캐리어 5중량%를 넣은 치약과 나노 캐리어를 사용하지 않고 토코페롤 0.2중량%, 유용성 감초 추출물 0.001중량%, 발삼추출물 0.50중량%를 함유하는 일반 치약을 이용하여 경피흡수실험을 수행하였다. 이를 위하여 기니아 피그를 사용하였다. 기니아 피그의 협낭 부위의 피부를 절취하여 프란츠형 투과셀(Frans-type diffusion cells, lab Fine Instruments)에 장착하여 실험하였다. 프란츠형 투과셀 용기의 리셉터(receptor) 용기에 5㎖의 증류수를 넣어주고, 투과셀은 32℃를 유지해주면서 600rpm으로 혼합 분산시켜 주었으며, 상기 각 시료 300㎕를 도너(dornor) 용기에 넣어 5분간 유지하였다. 그 다음, 증류수 1㎖를 첨가한 후 2분 동안 유지한 후 시료와 증류수 혼합액을 제거하였으며 이러한 과정을 10회 반복하여 실시하였다.Percutaneous absorption experiment using a toothpaste containing 5% by weight of the nanocarrier prepared in Example 2 and a general toothpaste containing 0.2% by weight of tocopherol, 0.001% by weight of useful oil licorice extract, and 0.50% by weight of balsam extract Was performed. Guinea pigs were used for this purpose. The skin of the guinea pig's buccal region was cut out and mounted in Frans-type diffusion cells (lab Fine Instruments). 5 ml of distilled water was put into a receptor vessel of a Franz-type permeation cell vessel, and the permeation cell was mixed and dispersed at 600 rpm while maintaining 32 ° C. 300 μl of each sample was placed in a donor vessel for 5 minutes. Maintained. Then, after adding 1ml of distilled water and maintaining for 2 minutes, the sample and the distilled water mixture was removed, and this process was repeated 10 times.

흡수 확산이 일어나는 피부의 면적은 0.64㎠가 되게 하였으며 나노 캐리어의 흡수 확산이 끝난 후에는 증류수 1㎖로 피부 표면을 세척하고, 에탄올 6㎖에 팁 타입 균등기(Polytron PT2100, Switzerland)를 사용하여 유효 성분이 흡수 확산되어 있는 피부를 갈아준 후, 추출액을 0.45㎛ 나일론 여과막을 사용하여 여과하고 고압 액체 크로마토그래피 방법으로 함량을 측정하였다.The area of skin where absorption and diffusion occurs is 0.64cm2. After the absorption diffusion of nanocarrier is finished, the skin surface is washed with 1 ml of distilled water, and 6 ml of ethanol is effective by using a tip type equalizer (Polytron PT2100, Switzerland). After the skin of which the components were absorbed and diffused was changed, the extract was filtered using a 0.45 µm nylon filtration membrane and the content was measured by high pressure liquid chromatography.

피부속으로 침투된 정도를 나타내는 나노 캐리어 토코페롤의 피부 투과율은 일반 치약의 경우 0.118%였고, 나노캐리어를 함유한 치약의 경우에는 0.189%로, 나노 캐리어의 피부 투과율이 60%정도 우수한 것으로 나타났다. 결과로서, 나노캐리어가 초산토코페롤의 협낭흡수를 촉진하고 있음을 확인할 수 있었다The skin permeability of the nanocarrier tocopherol, which indicates the degree of penetration into the skin, was 0.118% for the toothpaste, 0.189% for the toothpaste containing the nanocarrier, and the skin permeability of the nanocarrier was about 60%. As a result, it was confirmed that the nanocarrier promotes the absorption of buccal sac of tocopherol acetate.

실시예 4 : 일반 치약과 나노 캐리어 함유 치약의 열 및 빛에 의한 색상 변화 측정Example 4 Measurement of Color Change by Heat and Light of General Toothpaste and Nanocarrier-containing Toothpaste

25℃+차광조건, 40℃, 광노출(Light exposure) 조건으로 실시예 2에서 제조된 나노 캐리어 함유치약과 일반 치약을 한달 동안 방치한 후 색상 변화를 크로마미터(Chroma meter)로 측정하였다.After changing the nanocarrier-containing toothpaste and the general toothpaste prepared in Example 2 under 25 ° C. + light shielding condition, 40 ° C., and light exposure conditions, color change was measured by a chroma meter.

시간이 경과하면서 유용성 감초는 열과 빛에 의해 색상이 변화하는데, 나노 캐리어 함유 치약의 경우가 일반 치약에 비해 광노출(Light exposure) 조건에서는 약 2배, 40℃에서는 약 1.5배, 25℃+차광조건에서는 3배 정도 안정한 것으로 나타났다.As time passes, oil-soluble licorice changes color due to heat and light.In contrast, toothpaste containing nanocarrier is about 2 times under light exposure condition, about 1.5 times under 40 ℃, and 25 ℃ + shading compared to general toothpaste. It was found to be about three times stable under the conditions.

실시예 5 : 치은염 완화 효과 측정Example 5 Measurement of Gingivitis Mitigation Effect

본 발명의 나노 캐리어가 함유된 치약의 잇몸질환 예방효과를 확인하기 위해서 치은지수를 측정하였다.To determine the gum disease prevention effect of the toothpaste containing the nanocarrier of the present invention was measured gingival index.

피검자 20명을 선별한 후 치은염 지수를 Talbott, Mandel and Chilton이 변형한 Le의 치은염 평점 기준에 따라 측정하였다.After selecting 20 subjects, the gingivitis index was measured according to Le's gingivitis rating criteria modified by Talbott, Mandel and Chilton.

(Talbott, Mandel and Chilton이 변형한 Le의 치은염 지수)(Le's gingivitis index, modified by Talbott, Mandel and Chilton)

Le의 치은염 평점기준Le Gingivitis Rating Criteria

0 : 염증 없음0: no inflammation

1: 경미 치은염(색조의 약한 변화 및 약한 부종) 치주낭심 측정시 출혈없음1: Mild gingivitis (weak change of color and weak edema) No bleeding during periodontal cyst measurement

2: 중등 치은염(발적, 부종) 치주낭심 측정시 출혈2: moderate gingivitis (redness, edema) bleeding during periodontal cyst measurement

3: 고도 치은염(궤양) 저절로 출혈되는 경향3: tendency to bleed due to high gingivitis (ulcer)

나노 캐리어 함유치약Nano carrier-containing toothpaste 일반 치약Generic toothpaste 초기치Initial value 1.70±0.181.70 ± 0.18 1.69±0.111.69 ± 0.11 1주1 week 1.10±0.181.10 ± 0.18 1.51±0.121.51 ± 0.12 2주2 weeks 0.61±0.140.61 ± 0.14 1.10±0.281.10 ± 0.28

상기 표 1은 치은염 지수 측정 결과를 나타내는 것으로서, 표 1에서 볼 수 있는 바와 같이, 나노 캐리어를 함유한 치약이 일반 치약에 비하여 점막을 통한 경피 흡수율이 우수하여 치은염 완화 효과가 매우 우수한 것으로 나타났다Table 1 shows the results of the gingivitis index measurement, as shown in Table 1, the toothpaste containing nanocarriers was found to have a very good gingivitis relieving effect as compared to the general toothpaste has a superior percutaneous absorption rate through the mucosa.

본 발명에 의하면, 구강에 유효한 성분임에도 불구하고 체내 흡수력이 낮은 감초, 토코페롤, 발삼 등이 함유된 조성물을 나노 캐리어로 안정화시킴으로써, 상기 유효성분들의 구강 점막 침투력을 증가시킬 수 있게 된다. According to the present invention, the composition containing licorice, tocopherol, balsam, etc., which have low absorption in the body despite being an effective ingredient in the oral cavity, is stabilized with a nanocarrier, thereby increasing the oral mucosal penetration of the active ingredients.

또한, 본 발명에 의하면, 변색이 잘 되는 감초의 경우에도 열 및 빛에 대한 안정성을 나타내게 된다.In addition, according to the present invention, even in the case of licorice that discolors well, it exhibits stability to heat and light.

따라서, 본 발명에 의하여 제조된 나노 캐리어를 구강위생 제품에 이용할 경우, 상기 제품 내에서의 구강용 약효 성분의 안정성을 향상시킬 수 있을 뿐 아니라, 피부 및 잇몸, 체내에서의 침투력이 증가되어 우수한 치은염 및 치주질환 예방 효과를 얻을 수 있게 된다.Therefore, when the nanocarrier prepared according to the present invention is used in an oral hygiene product, not only can improve the stability of the oral medicinal components in the product, but also penetrates the skin, gums and body to increase the excellent gingivitis And periodontal disease prevention effect can be obtained.

Claims (2)

레시틴 1-5.00중량%, 에탄올 1-20.00중량%, 카프릭/카프릴릭 트리글리세라이드 1-5.00중량%, 발삼추출물 1-20.00중량%, 토코페롤 아세테이트 1-20.00중량%, 유용성 감초 추출물 0.001-1.00중량%, 세틸포스페이트 0.01-1.00중량%, 비타민 C 0.001-1.00중량%, BHT 0.1-0.5중량%, 정제수(balance)를 포함하는 나노 캐리어 조성물.1-5.00% lecithin, 1-20.00% ethanol, 1-5.00% capric / caprylic triglyceride, 1-20.00% balsam extract, 1-20.00% tocopherol acetate, oil-soluble licorice extract 0.001-1.00 A nanocarrier composition comprising: wt%, cetylphosphate 0.01-1.00 wt%, vitamin C 0.001-1.00 wt%, BHT 0.1-0.5 wt%, purified water (balance). 제 1 항의 나노 캐리어 조성물에 의하여 제조된 나노 캐리어를 포함하는 치약.Toothpaste comprising a nanocarrier prepared by the nanocarrier composition of claim 1.
KR1020040024228A 2004-04-08 2004-04-08 Composition for nano carrier comprising extract of licorice, tocopherol and balsam, oral care product using it KR100687037B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040024228A KR100687037B1 (en) 2004-04-08 2004-04-08 Composition for nano carrier comprising extract of licorice, tocopherol and balsam, oral care product using it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040024228A KR100687037B1 (en) 2004-04-08 2004-04-08 Composition for nano carrier comprising extract of licorice, tocopherol and balsam, oral care product using it

Publications (2)

Publication Number Publication Date
KR20050098701A KR20050098701A (en) 2005-10-12
KR100687037B1 true KR100687037B1 (en) 2007-02-27

Family

ID=37278114

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040024228A KR100687037B1 (en) 2004-04-08 2004-04-08 Composition for nano carrier comprising extract of licorice, tocopherol and balsam, oral care product using it

Country Status (1)

Country Link
KR (1) KR100687037B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102221423B1 (en) * 2019-08-27 2021-03-02 주식회사 닥터이엘 Composition for inhibiting halitosis and enhancing oral hygiene

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010101257A (en) * 1998-12-18 2001-11-14 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010101257A (en) * 1998-12-18 2001-11-14 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system

Also Published As

Publication number Publication date
KR20050098701A (en) 2005-10-12

Similar Documents

Publication Publication Date Title
JP2544198B2 (en) Composition based on a hydratable lamellar phase or liposome consisting of an extract of mulberry and a pharmaceutical composition, in particular a dermatological composition with skin lightening or anti-inflammatory activity, or a cosmetic composition Stuff
RU2418575C2 (en) Nanoliposome with application of etherificated lecitin and method of obtaining such, as well as composition for prevention or treatment of skin diseases including such liposomes
CA2685845C (en) Liquorice extract antimicrobial and anti-inflammatory isolates
AU2014415225B2 (en) Oral care products and methods of use and manufacture thereof
LT4828B (en) COMPOSITION FOR HALITASE TREATMENT
KR100821998B1 (en) Cosmetic preparation containing vitamin a
KR20150132404A (en) Polyphenol/flavonoid compositions and methods of formulating oral hygienic products
KR101595530B1 (en) Liposome composition having excellent effect of skin wrinkle improvement and skin whitening for accelerating percutaneous absorption
FR2921253A1 (en) COSMETIC COMPOSITION IN THE FORM OF EMULSION COMPRISING A CONTINUOUS AQUEOUS PHASE AND A DISPERSED FATTY PHASE AND PROCESS FOR PREPARING THE SAME
JP2011093880A (en) Anti-inflammatory composition, and skin preparation for external use, cosmetic and health food containing the same
KR101627051B1 (en) Natural liposome comprising vitamin C, process for the preparation thereof, and cosmetic composition comprising the same
EP2100593B1 (en) Ternary mixtures with increased collagen synthesis
EP2996666B1 (en) Dentifrice compositions containing extracts of nigella sativa and related methods
JP3715895B2 (en) Method for producing plant extract powder and composition for oral cavity containing plant extract powder produced by this method
KR20110027047A (en) Zeolite oral capsule powder and the oral composition containing thereof
CN104066417B (en) Oral care composition comprising isobutyl magnolol
KR100489267B1 (en) Oral care composition comprising nanoparticulated cinnamon extract
KR100687037B1 (en) Composition for nano carrier comprising extract of licorice, tocopherol and balsam, oral care product using it
KR20110067358A (en) Calendula officinalis dentifrice composition and process for preparing the same
KR101497191B1 (en) Skin Care Composition having Removing effect of Sebum and Black Head to Capsulate Natural Extracts as Multi-Capsule Vesicles, and Cosmetics containing Their Materials
DE102017009626A1 (en) Oral composition with citrus extract and hydroxyapatite
US8877266B2 (en) Supercritical CO2 liquorice extract anti-microbial and anti-inflammatory isolates and products made there from
KR100614816B1 (en) A stable nanocapsule compositon and cosmetic composition comprising the same
US11737969B2 (en) Mineral treatment method for damaged teeth
DE10261815B4 (en) Relaxing cosmetic with temperature effect

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130320

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140211

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150217

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20160219

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170111

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20180220

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20190207

Year of fee payment: 13